Q-linea's partner Thermo Fisher is launching ASTar in Europe, and Q4 is the first quarter featuring most of the launch (as of 7th of October). Recent progress includes expanding the ASTar panel, a positive evaluation study, first commercial evaluation, and Q-linea have started compiling the US 510(k) application. Q-linea is executing supported by a strong partner and a solid financial position. Our value proposition is a base of SEK 180 (Bull SEK 230 and Bear SEK 90).
LÄS MER